Name | PRODIGIOSIN |
Synonyms | PRODIGIOSIN Prodigiosine 4-Methoxy-5-[(5-methyl-4-pentyl-2H-pyrrol-2-ylidene)methyl], 2,2'bipyrrole 4-Methoxy-5-(4-pentyl-5-methyl-2H-pyrrole-2-ylidenemethyl)-2,2'-bi[1H-pyrrole] 4-Methoxy-5-[(5-methyl-4-pentyl-2H-pyrrol-2-ylidene)methyl]-2,2'-bi[1H-pyrrol] 4-Methoxy-5-[(5-methyl-4-pentyl-2H-pyrrol-2-ylidene)methyl]-2,2'-bi[1H-pyrrole] (Z)-4-Methoxy-5-((5-Methyl-4-pentyl-2H-pyrrol-2-ylidene)Methyl)-1H,1'H-2,2'-bipyrrole 3-Methoxy-2-(5-methyl-4-pentyl-2H-pyrrol-2-ylidene)methyl-5-(1H-pyrrol-2-yl)-1H-pyrrole |
CAS | 82-89-3 |
Molecular Formula | C20H25N3O |
Molar Mass | 323.43 |
Density | 1.12±0.1 g/cm3(Predicted) |
Melting Point | 151-152° |
Boling Point | 554.3±50.0 °C(Predicted) |
Solubility | Insuluble (5.8E-3 g/L) (25 °C) |
Appearance | Light brown to reddish brown (Solid) |
pKa | 17.09±0.50(Predicted) |
Storage Condition | -20C |
biological activity | Prodigiosine, a natural red pigment, it is a secondary metabolite with biological activity. Prodigiosin is a potent inhibitor of the Wnt/β-catenin pathway. Prodigiosin has antibacterial, antifungal, antiprotozoal, antimalarial, immunosuppressive and anticancer properties. |
Cell Line: | MDA-MB-231 and MDA-MB-468 cells HEK293T cells |
Concentration: | 10 nM, 25 nM, 50 nM, 100 nM, 250 nM, 500 nM, 1000 nM, 2500 nM, 5000 nM 50 nM, 100 nM, 250 nM, 500 nM |
Incubation Time: | 24 hours, 48 hours 24 hours |
Result: | Reduced the viability of breast cancer cells, with IC 50 values at 48 h of 62.52 nM in MDA-MB-231 cells and 261.2 nM in MDA-MB-468 cells. Significantly reduced the levels of phosphorylated LRP6 and DVL2, active β-catenin, and total β-catenin. Significantly inhibited tumor growth in mice. |
Animal Model: | Female BALB/c nude mice injected with MDA-MB-231 cells |
Dosage: | 5 mg/kg |
Administration: | Intraperitoneal injection; twice weekly; for 3 weeks |